Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:5:p2
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 5 (pt 2/22)
Character Range: 253691–256703

alpha‑cypermethrin; or
 (b) in other preparations containing 1.5% or less of alpha‑cypermethrin.
AMETRYN.
AMINES for use as curing agents for epoxy resins except when separately specified in these Schedules.
AMINOACRIDINE in preparations for veterinary use containing 2.5% or less of aminoacridine.
AMINOCYCLOPYRACHLOR except in preparations containing 25% or less of aminocyclopyrachlor.
AMINOPYRALID in preparations containing 22% or less of aminopyralid.
AMISULBROM.
AMITROLE.
AMMONIA (excluding its salts and derivatives other than ammonium hydroxide) in preparations containing 5% or less of ammonia except:
 (a) in preparations for human internal therapeutic use; or
 (b) in preparations for inhalation when absorbed in an inert solid material; or
 (c) in preparations containing 0.5% or less of free ammonia.
AMMONIUM THIOCYANATE except in preparations containing 10% or less of ammonium thiocyanate.
ANHYDRIDES, ORGANIC ACID for use as curing agents for epoxy resins except when separately specified in these Schedules.
ANISE OIL except:
 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert, and labelled with the warning:

           KEEP OUT OF REACH OF CHILDREN; or
 (c) in preparations containing 50% or less of anise oil.
ASPIRIN for the treatment of animals, that is in divided preparations, when:

       (a) packed in blister or strip packaging; or

       (b) in a container with a child-resistant closure.
ATRAZINE.
AZADIRACHTA INDICA EXTRACTS (neem extracts), extracted from neem seed kernels using water, methanol or ethanol, in preparations containing 5% or less of total limonoids, for agricultural use.
AZELAIC ACID except when included in Schedule 2 or 4.
AZOXYSTROBIN.
BACILLUS THURINGIENSIS DELTA ENDOTOXIN encapsulated in killed Pseudomonas fluorescens.
BARIUM SILICOFLUORIDE when coated on paper in an amount not exceeding 8 mg of barium silicofluoride per sq. cm.
BASIL OIL except:
 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert, and labelled with the warning:

           KEEP OUT OF REACH OF CHILDREN; or
 (c) in preparations containing 5% or less of methyl chavicol.
BEAUVERIA BASSIANA in preparations containing 1 x 108 Colony Forming Units (CFu)/mL or less of Beauveria bassiana.
BENALAXYL.
BENDIOCARB in preparations containing 2% or